We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 28.20 | 27.50 | 28.20 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 48.48M | -776k | -0.0011 | -256.36 | 190.37M |
From May 2022 to May 2024
By Ian Walker
Open Orphan PLC said Thursday that it has been made aware by Irish authorities of potential insider dealing in its shares by an unconnected private individual in 2020, and that the company is helping them with their inquires.
The London-listed pharmaceutical-services and research company said that no employee, executive, director or anyone else connected with the company had any involvement in this matter, nor are they suspected of any wrongdoing.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
September 15, 2022 02:47 ET (06:47 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
